Venomics AI Raises $2.7 Million to Turn Venom Into Drugs
IISc spin-out Venomics AI has raised $2.7 million led by Speciale Invest and South Park Commons to find new drugs in animal venom using AI.
IISc spin-out Venomics AI has raised $2.7 million led by Speciale Invest and South Park Commons to find new drugs in animal venom using AI.
OpenAI has released GPT-6 Rosalind, a frontier biology and drug-discovery model on GPT-6 Astra’s weights, only to vetted research organisations at premium prices. It is rated High risk for biology. Indian pharma companies can apply, but the free academic plan covers only US university labs.